X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (74) 74
female (72) 72
index medicus (64) 64
oncology (64) 64
middle aged (51) 51
adult (48) 48
breast cancer (48) 48
aged (47) 47
breast neoplasms - drug therapy (39) 39
breast neoplasms - pathology (29) 29
article (28) 28
cancer (27) 27
treatment outcome (26) 26
antineoplastic combined chemotherapy protocols - therapeutic use (24) 24
aged, 80 and over (21) 21
male (21) 21
chemotherapy (20) 20
antineoplastic combined chemotherapy protocols - adverse effects (18) 18
breast neoplasms - genetics (18) 18
trastuzumab (18) 18
medicine & public health (17) 17
therapy (17) 17
antineoplastic agents - therapeutic use (16) 16
care and treatment (16) 16
metastasis (15) 15
prognosis (15) 15
tumors (15) 15
survival (14) 14
clinical trials (13) 13
kaplan-meier estimate (13) 13
mutation (13) 13
neoplasms - drug therapy (13) 13
patients (13) 13
research (13) 13
disease-free survival (12) 12
solid tumors (11) 11
breast neoplasms - metabolism (10) 10
dosage and administration (10) 10
drug therapy (10) 10
health aspects (10) 10
maximum tolerated dose (10) 10
neoplasm metastasis (10) 10
pharmacology & pharmacy (10) 10
abridged index medicus (9) 9
antineoplastic agents - administration & dosage (9) 9
breast neoplasms - mortality (9) 9
metastases (9) 9
neoadjuvant therapy (9) 9
neoplasm staging (9) 9
pharmacology/toxicology (9) 9
bevacizumab (8) 8
breast (8) 8
cancer therapies (8) 8
drug administration schedule (8) 8
erbb-2 protein (8) 8
phosphatidylinositol 3-kinases - genetics (8) 8
analysis (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (7) 7
cell lung-cancer (7) 7
docetaxel (7) 7
dose-response relationship, drug (7) 7
doxorubicin - administration & dosage (7) 7
gene expression profiling (7) 7
metastatic breast cancer (7) 7
neoplasms (7) 7
phase-ii (7) 7
animals (6) 6
antibodies, monoclonal, humanized (6) 6
antineoplastic agents - adverse effects (6) 6
biomarkers (6) 6
class i phosphatidylinositol 3-kinases (6) 6
combination (6) 6
diagnosis (6) 6
epidermal growth factor (6) 6
genetic aspects (6) 6
her2 (6) 6
lapatinib (6) 6
metformin (6) 6
neoplasms - pathology (6) 6
paclitaxel (6) 6
paclitaxel - administration & dosage (6) 6
protein kinase inhibitors - adverse effects (6) 6
protein kinase inhibitors - therapeutic use (6) 6
quinazolines - administration & dosage (6) 6
receptor, erbb-2 - genetics (6) 6
receptor, erbb-2 - metabolism (6) 6
recommendations (6) 6
resistance (6) 6
targeted therapy (6) 6
toxicity (6) 6
young adult (6) 6
adolescent (5) 5
antibodies, monoclonal - administration & dosage (5) 5
antibodies, monoclonal, humanized - administration & dosage (5) 5
antimitotic agents (5) 5
antineoplastic agents (5) 5
antineoplastic agents - pharmacology (5) 5
biomarkers, tumor (5) 5
cancer research (5) 5
carboplatin (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 05/2015, Volume 75, Issue 9 Supplement, pp. P5 - P5-05-05
Journal Article
npj Breast Cancer, ISSN 2374-4677, 12/2018, Volume 4, Issue 1, pp. 9 - 12
Tumor cells disseminate early in tumor development making metastasis-prevention strategies difficult. Identifying proteins that promote the outgrowth of... 
Breast cancer | Metastasis | Gene expression | Cell adhesion & migration
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. 578 - 578
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2014, Volume 32, Issue 26_suppl, pp. 107 - 107
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 4275 - 4275
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 1, pp. 23 - 34
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2014, Volume 32, Issue 26_suppl, pp. 146 - 146
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 1, pp. 11 - 22
Journal Article
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 07/2017, Volume 23, Issue 14, pp. 3529 - 3536
Purpose: ONT-380 (ARRY-380) is a potent and selective oral HER2 inhibitor. This Phase I study determined the MTD, pharmacokinetics (PK) and antitumor activity... 
LAPATINIB | CAPECITABINE | GROWTH-FACTOR RECEPTOR | THERAPY | TRASTUZUMAB | EFFICACY | ONCOLOGY | BRAIN METASTASES | NERATINIB | COMBINATION | Protein Kinase Inhibitors - pharmacokinetics | Breast Neoplasms, Male - genetics | Receptor, Epidermal Growth Factor - genetics | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Male | Breast Neoplasms, Male - drug therapy | Protein Kinase Inhibitors - adverse effects | Breast Neoplasms - drug therapy | Drug-Related Side Effects and Adverse Reactions - pathology | Dose-Response Relationship, Drug | Protein Kinase Inhibitors - administration & dosage | Maximum Tolerated Dose | Neoplasm Metastasis | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Adult | Female | Aged | Receptor, ErbB-2 - antagonists & inhibitors | Breast Neoplasms, Male - pathology | Drug-Related Side Effects and Adverse Reactions - classification | Toxicity | Exanthema | Metastases | Anticancer properties | Pain | Vomiting | Quality | Hypokalemia | Constipation | Expansion | Epidermal growth factor receptors | Anemia | Diarrhea | Fatigue | Radioactive half-life | Nausea | Breast cancer | Pharmacology | Patients | ErbB-2 protein | Cough | Inhibitors | Experimental design | Design modifications | Transaminases | Antitumor activity | Solid tumors | Pharmacokinetics | Tumors | Cancer | Index Medicus
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e12111 - e12111
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.